Butamirate citrate (Miracit), is a cough suppressant which is neither chemically nor pharmacologically related to opium alkaloids. Its acts centrally by diminishing the tussigenic reflex and peripherally via a bronchospasmolytic activity enhanced by an anti-inflammatory action. Butamirate citrate also increases the spirometry indexes & blood oxygenation. Butamirate citrate (Miracit) does not induce habit-forming effects or dependence.
Each 5 ml syrup contains Butamirate Citrate INN 7.5 mg.
Miracit is indicated in acute cough of any etiology, pre and post-operative cough sedation for surgical procedure and bronchoscopy.
Children 3 - 6 years: 5 ml 3 times daily.
Children 6 - 12 years: 10 ml 3 times daily.
Adolescents over 12 years: 15 ml 3 times daily.
Adults: 15 ml 4 times daily.
Hypersensitivity to the active substance.
Consult with doctor if any side effects may experience.
Butamirate is well tolerated. In rare cases, skin rash, nausea, diarrhea, dizziness has been reported. They disappear after reduction of the dosage or discontinuation of the drug.
Concomitant use with expectorants should be avoided.
Pregnancy & lactation: Butamirate should not be used in the first trimester of pregnancy. During the second and third trimesters of pregnancy, butamirate should be administered only if necessary, to use medicines. Butamirate syrup should be carefully considered in case of breastfeeding.
Each bottle contains 100 ml syrup.
FR
DE
